Pathogenic Mitochondrial DNA Mutation Load Inversely Correlates with Malignant Features in Familial Oncocytic Parathyroid Tumors Associated with Hyperparathyroidism-Jaw Tumor Syndrome
Authors:
- Monica De LuiseMLMonica De Luise
- Luisa IommariniLuisa Iommarini
- Lorena MarchioLMLorena Marchio
- Greta TedescoGTGreta Tedesco
- Camelia Alexandra CoadăCCCamelia Alexandra Coadă
- Andrea RepaciARAndrea Repaci
- Daniela TurchettiDaniela Turchetti
- Maria Lucia TardioMTMaria Lucia Tardio
- Nunzio SalfiNSNunzio Salfi
- Uberto PagottoUPUberto Pagotto
- Ivana KurelacIKIvana Kurelac
- Anna Maria PorcelliAPAnna Maria Porcelli
Open Access
Abstract
While somatic disruptive mitochondrial DNA (mtDNA) mutations that severely affect the respiratory chain are counter-selected in most human neoplasms, they are the genetic hallmark of indolent oncocytomas, where they appear to contribute to reduce tumorigenic potential. A correlation between mtDNA mutation type and load, and the clinical outcome of a tumor, corroborated by functional studies, is currently lacking. Recurrent familial oncocytomas are extremely rare entities, and they offer the chance to investigate the determinants of oncocytic transformation and the role of both germline and somatic mtDNA mutations in cancer. We here report the first family with Hyperparathyroidism-Jaw Tumor (HPT-JT) syndrome showing the inherited predisposition of four individuals to develop parathyroid oncocytic tumors. MtDNA sequencing revealed a rare ribosomal RNA mutation in the germline of all HPT-JT affected individuals whose pathogenicity was functionally evaluated via cybridization technique, and which was counter-selected in the most aggressive infiltrating carcinoma, but positively selected in adenomas. In all tumors different somatic mutations accumulated on this genetic background, with an inverse clear-cut correlation between the load of pathogenic mtDNA mutations and the indolent behavior of neoplasms, highlighting the importance of the former both as modifiers of cancer fate and as prognostic markers.Keywords
Funding Information
- Worldwide Cancer Research (15-1144)
- EU H2020 Marie Curie project TRANSMIT (GA 722605)
This publication has 72 references indexed in Scilit:
- Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)Oncology Letters, 2012
- Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumorsBMC Cancer, 2012
- A randomised controlled trial of a theory-based intervention to improve sun protective behaviour in adolescents ('you can still be HOT in the shade'): study protocolBMC Cancer, 2012
- HmtDB, a genomic resource for mitochondrion-based human variability studiesNucleic Acids Research, 2011
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Detection of nonneutral substitution rates on mammalian phylogeniesGenome Research, 2009
- NDUFS4: Creation of a mouse model mimicking a Complex I disorderMitochondrion, 2009
- Loss of Complex I due to Mitochondrial DNA Mutations in Renal OncocytomaClinical Cancer Research, 2008
- Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumorsProceedings of the National Academy of Sciences, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004